Cargando…
Effect of sodium–glucose cotransporter 2 inhibitor medication on new prescriptions of antihypertensives, antigout/antihyperuricemics and antidyslipidemics in Japan: Analysis using the JMDC Claims Database
AIMS/INTRODUCTION: This study aimed to investigate the effects of sodium–glucose cotransporter 2 inhibitors (SGLT2i) on new prescriptions of drugs, including antihypertensives, antigout/antihyperuricemics and antidyslipidemics, for the treatment of lifestyle‐related diseases in Japanese patients wit...
Autores principales: | Gouda, Maki, Arakawa, Kenji, Inagaki, Masaya, Ushirogawa, Yoshiteru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623520/ https://www.ncbi.nlm.nih.gov/pubmed/35854644 http://dx.doi.org/10.1111/jdi.13887 |
Ejemplares similares
-
Studies on the antihypertensive and antidyslipidemic activities of Viola odorata leaves extract
por: Siddiqi, Hasan S, et al.
Publicado: (2012) -
Antihypertensive, antidyslipidemic, and renoprotective effects of Bursera simaruba on metabolic syndrome
por: Alejandrina Guzmán Hernández, Elizabeth, et al.
Publicado: (2023) -
Data resource profile: JMDC claims databases sourced from Medical Institutions
por: Nagai, Katsuhiko, et al.
Publicado: (2020) -
Data resource profile: JMDC claims database sourced from health insurance societies
por: Nagai, Katsuhiko, et al.
Publicado: (2021) -
Studies on two polyherbal formulations (ZPTO and ZTO) for comparison of their antidyslipidemic, antihypertensive and endothelial modulating activities
por: Aziz, Nauman, et al.
Publicado: (2013)